welbournes

The Department of Health and Social Care (DHSC) has today (30/04/2026) confirmed the following list of price concessions for April 2026. Community Pharmacy England has issued a statement in response: Record concession numbers indicative of volatility in supply chain, warns CPE. This list for April 2026 includes twelve further price concessions and improved prices for [...]

The post April 2026 Price Concessions 5th update including improved prices appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/04/2026) confirmed the following list of price concessions for April 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post April 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (24/04/2026) confirmed the following list of price concessions for April 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post April 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Ramipril 1.25mg capsules. MSN/2026/022 Tier 2 – Medium impact Date of issue: 23 April 2026 There are intermittent supply issues with ramipril 1.25mg capsules until the end of May 2026. Ramipril 1.25mg and 2.5mg tablets and ramipril oral solution remain available [...]

The post Medicine Supply Notification: Ramipril 1.25mg capsules appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Limited) Drug alert number: EL(26)A/20 Date issued: 22 April 2026 Doncaster Pharma Limited has informed the MHRA of an error related to the Braille embossing on the outer packaging of the above mentioned parallel imported batches of Hiprex 1 g tablets (POM). It was identified [...]

The post MHRA Class 4 Medicines Defect Notification: Hiprex 1g tablets (Doncaster Pharma Ltd) appeared first on Community Pharmacy England.